ストックスクリーナーアプリを入手
411.19
0.12%
0.5394
前日終値:
$410.65
開ける：
$409.54
24時間の取引高:
1.59M
Relative Volume:
0.62
時価総額：
$156.49B
収益：
$42.90B
当期純損益:
$6.52B
株価収益率:
24.12
EPS:
17.05
ネットキャッシュフロー:
$6.72B
1週間 パフォーマンス:
+4.73%
1か月 パフォーマンス:
+4.44%
6か月 パフォーマンス:
-22.01%
1年 パフォーマンス:
-26.34%
1日の値動き範囲:
$409.27
$415.31
1週間の範囲:
$390.50
$415.31
52週間の値動き範囲:
$385.46
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
名前
Thermo Fisher Scientific Inc
セクター
電話
(781) 622-1000
住所
168 THIRD AVENUE, WALTHAM, MA
TMO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
410.75 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
201.44 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
527.80 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.38 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
157.50 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-03-18 | 再開されました | Citigroup | Neutral |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-01-08 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-10-26 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-06 | 再開されました | Citigroup | Buy |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-07-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-07-13 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 繰り返されました | Barclays | Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 再開されました | Barclays | Overweight |
| 2021-10-20 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-14 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-07-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 繰り返されました | Needham | Buy |
| 2020-04-23 | 繰り返されました | Needham | Buy |
| 2020-01-31 | 繰り返されました | Needham | Buy |
| 2020-01-22 | 開始されました | Credit Suisse | Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-25 | 繰り返されました | Needham | Buy |
| 2019-07-16 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-05-23 | 繰り返されました | Needham | Strong Buy |
| 2019-04-22 | 繰り返されました | Needham | Strong Buy |
| 2019-04-16 | 繰り返されました | BofA/Merrill | Buy |
すべてを表示
Thermo Fisher Scientific Inc (TMO) 最新ニュース
Hyderabad-based CCMB, Thermo Fisher Scientific launch supply centre, aims at strengthening research in life sciences - Telangana Today
Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market - MSN
Thermo Fisher’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Thermo Fisher stock hits 52-week low at $390.45 - Investing.com
Thermo Fisher stock hits 52-week low at $390.45 By Investing.com - Investing.com South Africa
Thermo Fisher Scientific’s SWOT analysis: stock outlook amid acquisitions, tariffs - Investing.com
Thermo Fisher Scientific Unveils New Mass Spectrometers to Advance Scientific Discovery - Insider Monkey
Thermo Fisher Scientific introduces the next generation Thermo Scientific™ Vanquish™ Charged Aerosol Detector P Series for more sensitive detection of impurities - bio-itworld.com
Thermo Fisher Scientific (TMO) Opinions on Diagnostics Division Sale - Nasdaq
Thermo Fisher Scientific Could Divest Diagnostics Division for More than $4B - Medical Device and Diagnostic industry
Flow Cytometer | Thermo Fisher Scientific Inc. | Jun 2025 - Photonics Spectra
Thermo Fisher Scientific Awarded $94M Navy Occupational Dosimetry System Contract - ExecutiveBiz
Tufts Center Study Shows Significant Time Savings in Delivering Therapies to Patients with Thermo Fisher Scientific’s Accelerator™ Drug Development 360° CDMO and CRO Solutions - Business Wire
Ethris and Thermo Fisher partner on mRNA solutions - Yahoo Finance
Bioreactor Market Insights 2025-2033 | Leading Vendors: Thermo Fisher Scientific, GE Healthcare, Sartorius - openPR.com
Thermo Fisher (TMO) Eyes Future Growth with Strategic mRNA Deal and Acquisition - Daily Chhattisgarh News
Next-Gen Diagnostics Drive Biochips Market Growth: Thermo Fisher, Illumina, and PerkinElmer at the Forefront - openPR.com
Report: Biotech Research Firm Thermo Fisher Considers Selling Diagnostics Business - PYMNTS.com
Thermo Fisher Scientific Explores Diagnostics Exit Amid mRNA Expansion S&P 500 - Kalkine Media
Thermo Fisher Scientific (NYSE:TMO) Explores US$4 Billion Diagnostics Sale, Expands mRNA Collaboration - simplywall.st
Thermo Fisher Stock Hurt by Macroeconomic Woes, Tough Competition - MSN
Ethris and Thermo Fisher Partner to Streamline mRNA Therapeutics Development - BioPharm International
October 17th Options Now Available For Thermo Fisher Scientific (TMO) - Nasdaq
High Frequency Electrocautery Market Deep Research Report with - openPR.com
Deals of the day-Mergers and acquisitions - marketscreener.com
Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms - Business Wire
Thermo Fisher said to weigh sale of some diagnostic assets for $4B - MSN
Thermo Fisher (TMO) Plans $4 Billion Sale of Diagnostics Divisio - GuruFocus
Thermo Fisher (TMO) Considers $4B Sale of Diagnostic Assets - GuruFocus
Thermo Fisher Reportedly Plans to Sell Parts of Diagnostics Unit for $4 Billion - marketscreener.com
Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports - ET HealthWorld
Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports By Reuters - Investing.com
Thermo Fisher Plans to Sell Parts of Diagnostics Unit for $4 Billion, FT Reports - US News Money
Thermo Fisher aims to sell parts of its diagnostics business for $4 billion, FT reports - TradingView
Thermo Fisher aims to sell parts of its diagnostics business for $4bn - Financial Times
Thermo Fisher (TMO) Stock Shows Signs of Rebound After Challenging Year - Daily Chhattisgarh News
Plasmid Purification Market Exclusive Report with Detailed - openPR.com
Regeneron Genetics Center Selects Olink® Explore HT for Landmark Proteomics Study of 200,000 Patient Samples - Business Wire
APJ, EEMEA and LATAM Thermo Scientific AST plate guide - SelectScience
Brain Cancer Diagnostics Market Key Players AnalysisThermo - openPR.com
Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape - GlobeNewswire Inc.
Thermo Fisher (TMO) Closes with Minor Gains After Volatile Session, Stock Still Down Significantly for the Year - Daily Chhattisgarh News
Ex-Dividend Reminder: Gilead Sciences, CONMED and Thermo Fisher Scientific - Nasdaq
HSBC Adjusts Price Target on Thermo Fisher Scientific to $560 From $590 - marketscreener.com
Thermo Fisher Scientific highlights case for combining electron microscopy and microtomography - Metal Additive Manufacturing magazine
Thermo Fisher (TMO) Rallies Over 1%, But Still Faces Long-Term Headwinds - Daily Chhattisgarh News
$100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth This Much Today - Benzinga
Thermo Scientific Precis Methods - SelectScience
Thermo Scientific SureTect automation workflow - SelectScience
Thermo Fisher Cuts Annual Profit Outlook Amid Estimated $400M Tariff Hit - insights.citeline.com
Old National Bancorp Reduces Stake in Thermo Fisher Scientific - Zenopa
Thermo Fisher Scientific Inc (TMO) 財務データ
収益
当期純利益
現金流量
EPS
0.25%
0.25%
大文字化:
|
ボリューム (24 時間):